Retinalamin

Peptide

Retinalamin is retained as a catalog identity with independently verified primary-literature context. No qualified exposure model, dose recommendation, efficacy claim, or safety claim is provided.

Pharmacokinetic model

A route-level PK model for retinalamin is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.

Key facts

Category
Peptide
Suggested cadence
once daily

Research behind this entry

  1. Effects of peptides on proliferative activity of retinal and pigmented epithelial cells. Khavinson VKh, Zemchikhina VN, Trofimova SV, Malinin VV · Bulletin of experimental biology and medicine, 2003 DOI

    This citation reports a laboratory or cell study involving Retinalamin. It does not establish a qualified human dose, safety profile, efficacy claim, or pharmacokinetic route for this catalog record.

1 published study referenced in the app, each with a plain-language summary.